First randomized evaluation of safety, pharmacodynamics, and pharmacokinetics of BAY 1831865, an antibody targeting coagulation factor XI and factor XIa, in healthy men
Sign Up to like & getrecommendations! Published in 2022 at "Journal of Thrombosis and Haemostasis"
DOI: 10.1111/jth.15744
Abstract: Bleeding is a clinically significant issue with all current anticoagulants. Safer antithrombotic strategies are required. read more here.
Keywords: first randomized; evaluation safety; randomized evaluation; pharmacodynamics pharmacokinetics ... See more keywords